Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

Company Overview - Sanara MedTech Inc. is a medical technology company based in Fort Worth, Texas, focused on developing and commercializing transformative technologies aimed at improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound, and skincare markets [5][6] - The company markets and distributes a range of surgical, wound, and skincare products, primarily in the North American advanced wound care and surgical tissue repair markets [6] Product Portfolio - Sanara's product offerings include CellerateRX® Surgical Activated Collagen, FORTIFY TRG® Tissue Repair Graft, and FORTIFY FLOWABLE® Extracellular Matrix, along with advanced biologic products such as ACTIGEN™ Verified Inductive Bone Matrix and ALLOCYTE® Plus Advanced Viable Bone Matrix [6] - In the wound care market, products include BIAKŌS® Antimicrobial Skin and Wound Cleanser, BIAKŌS® Antimicrobial Wound Gel, and BIAKŌS® Antimicrobial Skin and Wound Irrigation Solution [6] Pipeline and Development - The company has a pipeline of potentially transformative product candidates targeting opportunistic pathogens, biofilm mitigation, wound re-epithelialization, necrotic tissue debridement, and cell-compatible substrates [6] - Sanara aims to drive its pipeline from concept to preclinical and clinical development while adhering to quality and regulatory requirements [6] Strategic Focus - The company is actively seeking long-term strategic partnerships that focus on products designed to improve clinical outcomes at a lower overall cost [6]